Sitatin Tablet 100 mg (Sitagliptin Phosphate Hydrate)
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.
MFDS item code 201502367 · Approved 2015.04.17
This product's status changed to Approval withdrawn on 2024.09.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood glucose control in patients with type 2 diabetes. It can be administered alone in patients who are starting treatment for the first time. However, if blood glucose control is difficult with monotherapy, it can be taken in conjunction with metformin. Additionally, this medication is added as a combination therapy when blood glucose control is insufficient with monotherapy or combination therapy of sulfonylureas, thiazolidinediones, and insulin. This medication can be used with various diabetes treatments to aid in effective blood glucose management. Therefore, it improves diabetes treatment in conjunction with dietary and exercise regimens.
When used as monotherapy or in combination therapy, this drug is administered at a dose of 100 mg once daily; the maximum daily dose is 100 mg. This drug may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this drug and periodically thereafter. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered without regard to the timing of dialysis.
This medication may cause severe allergic reactions after administration, so if symptoms like skin rash or difficulty breathing occur, it should be stopped immediately, and a doctor should be consulted. This medication may cause severe pancreatic inflammation known as pancreatitis, so if symptoms like abdominal pain, nausea, or vomiting appear, immediate medical attention should be sought. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and patients with allergies to this medication or its ingredients should also not take it. Patients with reduced kidney function need to adjust the dosage of this medication, so regular kidney function tests should be conducted, and it should be taken under a doctor's guidance. Hypoglycemic symptoms may occur while taking this medication, especially when taken with insulin or sulfonylureas, which can increase the risk of hypoglycemia, so blood glucose should be checked frequently, and symptoms should be monitored. Some patients may experience side effects such as headaches, upper respiratory infections, rhinitis, diarrhea, nausea, constipation, vomiting, muscle pain, limb pain, back pain, pruritus, thrombocytopenia, dyspepsia, dizziness, increased triglycerides in the blood, increased low-density lipoproteins, hyperglycemia, weight loss, hypernatremia, and erectile dysfunction; if symptoms are severe, consultation with a doctor is advised. Pregnant or breastfeeding women are advised not to take this medication as its safety has not been established, and special care should be taken in breastfeeding as this medication can be excreted in breast milk. Elderly patients may have reduced kidney function, so kidney function should be periodically evaluated before and during the use of this medication, and dosage adjustments may be necessary. In case of overdose, immediate medical attention should be sought for appropriate treatment, as this medication can be partially removed by hemodialysis. If symptoms such as joint pain or skin blisters appear while taking this medication, the doctor should be informed immediately, and medication should be discontinued if necessary. This medication may interact with other drugs, so if other medications are being taken, it is important to inform a doctor or pharmacist, especially when taken with insulin, sulfonylureas, digoxin, and cyclosporine.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is best to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the effectiveness of the medication safely.
Beige round, biconvex film-coated tablet
Company packaging unit
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Sitagliptin Phosphate Hydrate 32.13mg
Tablet · Prescription medication
Jong Kundang Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 32.125mg
Tablet · Prescription medication
Sinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.